Search

Your search keyword '"Fluticasone -- Usage"' showing total 14 results
Start Over Descriptor "Fluticasone -- Usage"
14 results on '"Fluticasone -- Usage"'

1. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children

Author

Ducharme, Francine M., Lemire, Chantal, Noya, Francisco J.D., Davis, G. Michael, Alos, Nathalie, Leblond, Helene, Savdie, Cheryl, Collett, Jean-Paul, Khomenko, Lyudmyla, Rivard, Georges, and Platt, Robert W.

Subjects
Fluticasone -- Complications and side effects, Fluticasone -- Health aspects, Fluticasone -- Usage, Wheeze -- Care and treatment, Placebos -- Usage, Placebos -- Physiological aspects, Corticosteroids -- Usage, Corticosteroids -- Physiological aspects, Children -- Health aspects
Abstract

The study explores the safety and efficacy of preemptive treatment with high-dose fluticasone in reducing the severity of recurrent virus-induced wheezing in children aged 1 to 6 years. Evidence suggests preemptive treatment with fluticasone, in comparison with placebo, reduces the use of rescue oral corticosteroids, but long-term use is associated with smaller gains in height and weight.

Published
2009

4. The Effects of One-Week Fluticasone Propionate Inhalation Therapy for Tc-99m DTPA Radioaerosol Distribution in Asthma of Children: A Preliminary Report

Author

A. -C. Chen, F. -J. Tsai, J. J. P. Tsai, C. -C. Lin, C. -C. Lee, and A. Kao

Subjects
Aerosol therapy -- Usage, Asthma in children -- Drug therapy, Fluticasone -- Usage
Abstract

Byline: A. -C. Chen (1), F. -J. Tsai (1), J. J. P. Tsai (2), C. -C. Lin (3), C. -C. Lee (4), A. Kao (4) Keywords: Fluticasone propionate inhalation therapy; Tc-99m DTPA radioaerosol; Asthma Abstract: This study evaluated the effects of fluticasone propionate inhalation therapy for the distribution pattern of Tc-99m DTPA radioaerosols in 10 children with asthma. The homogeneous degree of depositing Tc-99m DTPA radioaerosol was evaluated using a modified standard score system over the bilateral lungs. The baseline scores were calculated from Tc-99m DTPA radioaerosol inhalation lung scintigraphy before inhalation therapy (100 Aug fluticasone propionate two times daily for one week), and the scores were recalculated after inhalation therapy to evaluate the effects of one-week of fluticasone propionate inhalation therapy for Tc-99m DTPA radioaerosol distribution patterns. After one week of fluticasone propionate inhalation therapy, the scores were decreased in all of the 10 children, which may mean that the bronchial constriction degree due to asthma is decreased. In addition, there was a significantly statistical difference in the scores before and after one-week fluticasone propionate inhalation therapy (p &lt 0.05). In conclusion, one-week fluticasone propionate inhalation therapy could significantly improve the bronchial constriction due to asthma in children based on the evidence of Tc-99m DTPA radioaerosol inhalation lung scintigraphic findings. Author Affiliation: (1) Department of Pediatrics, China Medical University Hospital, Taichung, Taiwan (2) Graduate Institute of Bioinformatics, Taichung Healthcare and Management University, Taichung, Taiwan (3) Department of Family Medicine, China Medical College Hospital, Taichung, Taiwan (4) Department of Medical Research, China Medical College Hospital, No. 2, Yuh-Der Road, Taichung 404, Taiwan Article History: Accepted Date: 28/03/2003

Published
2003
Full Text
View/download PDF

5. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial

Subjects
Asthma -- Control, Asthma -- Drug therapy, Montelukast -- Usage, Montelukast -- Comparative analysis, Fluticasone -- Comparative analysis, Fluticasone -- Usage, Health, Health care industry
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2005.03.003 Byline: Robert S. Zeiger (a), Steven R. Bird (b), Michael S. Kaplan (c), Michael Schatz (a), David S. Pearlman (d), E. John Orav (e), Carolyn M. Hustad (b), Jonathan M. Edelman (b) Abstract: To determine whether montelukast is as effective as fluticasone in controlling mild persistent asthma as determined by rescue-free days. Author Affiliation: (a) Department of Allergy-Immunology, Kaiser Permanente Medical Center, Los Angeles, California (b) Merck & Co., Inc., West Point, Pennsylvania (c) Southern California Center for Medical Education, Los Angeles, California (d) Colorado Allergy and Asthma Centers, PC, Denver, Colorado (e) Brigham and Women's Hospital, Boston, Massachusetts. Article Note: (footnote) This work was supported by Merck & Co., Inc.

Published
2005

7. Montelukast add-on therapy is equivalent to salmeterol

Subjects
Montelukast -- Usage, Fluticasone -- Usage, Asthma -- Care and treatment, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

Asthma exacerbations can be equally protected against by using montelukast or salmeterol in conjunction with fluticasone, say researchers. Patients whose asthma is uncontrolled by fluticasone propionate alone are often prescribed [...]

Published
2003

8. Inhaled corticosteroids advocated for COPD

Subjects
Pulmonary circulation -- Research, Fluticasone -- Usage, Pharmaceutical industry -- Research, Chemicals, plastics and rubber industries, Pharmaceuticals and cosmetics industries
Abstract

New research suggests that Fluticasone propionate slows the decline in health and reduces the number of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease. The inhaled steroids [...]

Published
2000

9. Fluticasone propionate in asthma: a long-term, dose-comparison study

Author

Leickly, Frederick E.

Subjects
Fluticasone -- Usage, Asthma -- Case studies, Antiasthmatic agents -- Usage
Abstract

Verona E, Petrov D, Cserhati E, et al. Arch Dis Child. 2003;88:503-509 Purpose of the Study. To compare the efficacy and tolerability of 2 doses of fLuticasone propionate (FP), 100 [...]

Published
2004

10. Chronic necrotizing pulmonary aspergillosis or invasive pulmonary aspergillosis

Author

Du, Haijian and Huang, Weijie

Subjects
Pulmonary aspergillosis -- Diagnosis, Pulmonary aspergillosis -- Case studies, Pulmonary aspergillosis -- Risk factors, Pulmonary aspergillosis -- Care and treatment, Fluticasone -- Usage, Fluticasone -- Health aspects, Smoking -- Health aspects, Health
Published
2009

11. Another tool for a common problem

Subjects
Hay-fever -- Care and treatment, Hay-fever -- Reports, Respiratory agents -- Usage, Fluticasone -- Usage, Sleep apnea syndromes -- Care and treatment, Sleep apnea syndromes -- Reports, Health
Abstract

Synopsis: Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis. Source: Kiely JL, et al. Thorax. 2004;59:50-55. ********** KIELY AND COLLEAGUES STUDIED A TOTAL OF 23 patients with allergic [...]

Published
2004

13. Montelukast, fluticasone propionate similarly cut ED visits for asthma

Author

Wood, Debra

Subjects
Flovent (Medication) -- Usage, Asthma -- Drug therapy, Fluticasone -- Usage, Montelukast -- Usage
Abstract

ORLANDO, FLA. -- Medicaid patients with asthma responded similarly to monotherapy with either montelukast or fluticasone propionate in a study presented as a poster at the 100th International Conference of [...]

Published
2005

14. Pediatric Inhaled Corticosteroid Asthma Medication Features New Dose Counters to Help Track Usage

Subjects
Asthma in children -- Drug therapy, Corticosteroids -- Dosage and administration, Fluticasone -- Dosage and administration, Fluticasone -- Usage, Pediatric pharmacology
Abstract

GlaxoSmithKline announced the nationwide availability of two formulations of an inhaled corticosteroid (ICS) with a dose counter -- Flovent(R) HFA 44 mcg (fluticasone propionate 44 mcg inhalation aerosol) and Flovent(R) [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results